Image Source: Pexels

Gianni just booked 35% on a biotech name in his Trinity Trade portfolio this morning.

Everyone else, including myself, was focused on Microsoft and OpenAI.

That gap says everything about where the next AI wave is building.

Think about it… 

We've already beaten the semiconductor story to death. Nvidia NVDA, AMD, data centers. The market knows that playbook inside and out.

But AI in healthcare represents something fundamentally different. We're talking about tangible benefits for the general population, not just improved corporate margins from replacing workers.

Gianni's already positioning for this shift through Trinity Trade. 

The model has been detecting increasing institutional flows into biotech names for months. 

This morning, he booked that 35% gain on Qis Biotherapeutics after the stock gapped up 20% on earnings and continued rallying.

Here's what makes this setup compelling:

• Healthcare sector hasn't hit new all-time highs in 2025
• Biotech ETFs (XBI, IBB) haven't made new highs since 2021
• Lower interest rates create favorable conditions for biotech development
• Pro-business regulatory environment under current administration
• AI applications in drug discovery and healthcare delivery just getting started

The timing aligns with broader market strength. Technology reasserted itself as the top-performing sector last week. That risk-on signal gave Gianni confirmation the market would reward aggressive positioning. Nvidia continues pushing toward his $230 target. Tesla is trying to close at its highest level of the year. The Mag Seven names are doing exactly what you'd expect at this stage of the cycle.

But the real opportunity is in sectors that haven't participated yet.

Rate cuts amplify this thesis. When the Fed cuts tomorrow (which everyone already knows), capital hunts for growth in overlooked sectors. Biotech fits that profile perfectly.

The semiconductor story made fortunes for early movers. The biotech AI story is just beginning.

Video Length: 00:11:53

More By This Author: